, Calif., has filed for a public offering of 1.5 million shares of common stock. It develops and applies technology for discovering gene expression patterns and genomic variations.
The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.
